These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 9371286
1. Advances in the clinical use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor to intensify cancer chemotherapy. Fisher DC, Peters WP. Curr Opin Hematol; 1994 May; 1(3):221-7. PubMed ID: 9371286 [Abstract] [Full Text] [Related]
2. Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer. Willemse PH, Boonstra H, de Vries EG. Semin Oncol; 1994 Dec; 21(6 Suppl 16):44-50. PubMed ID: 7528450 [No Abstract] [Full Text] [Related]
3. Dose intensity in small cell lung cancer. Thatcher N, Lee SM, Woll PJ, Middleton M, Anderson H, Burt P, Stout R. Semin Oncol; 1998 Apr; 25(2 Suppl 4):12-8; discussion 45-8. PubMed ID: 9578057 [Abstract] [Full Text] [Related]
4. Clinical trials of granulocyte colony-stimulating factors for treatment of bone marrow depression associated with cancer chemotherapy. Lieschke GJ, Morstyn G. Immunol Ser; 1992 Apr; 57():671-93. PubMed ID: 1380312 [No Abstract] [Full Text] [Related]
5. Hematopoietic growth factors in cancer chemotherapy. Morstyn G, Foote M, Lieschke GJ. Cancer Chemother Biol Response Modif; 1996 Apr; 16():295-314. PubMed ID: 8639388 [No Abstract] [Full Text] [Related]
6. Interleukin-3 in hematology and oncology: current state of knowledge and future directions. Mangi MH, Newland AC. Cytokines Cell Mol Ther; 1999 Jun; 5(2):87-95. PubMed ID: 10515681 [Abstract] [Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor with dose-intensified treatment of cancer. Clark DA, Neidhart JA. Semin Hematol; 1992 Oct; 29(4 Suppl 3):27-32. PubMed ID: 1492231 [Abstract] [Full Text] [Related]
8. Hemopoietic growth factors: a review. Morstyn G, Burgess AW. Cancer Res; 1988 Oct 15; 48(20):5624-37. PubMed ID: 2458827 [Abstract] [Full Text] [Related]
13. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. Hübel K, Dale DC, Liles WC. J Infect Dis; 2002 May 15; 185(10):1490-501. PubMed ID: 11992286 [Abstract] [Full Text] [Related]
14. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells . Haas R, Murea S. Cytokines Mol Ther; 1995 Dec 15; 1(4):249-70. PubMed ID: 9384679 [Abstract] [Full Text] [Related]
15. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients. Palmeri S, Leonardi V, Danova M, Porta C, Ferrari S, Fincato G, Citarrella P. Haematologica; 1999 Nov 15; 84(11):1016-23. PubMed ID: 10553163 [Abstract] [Full Text] [Related]
18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. Root RK, Dale DC. J Infect Dis; 1999 Mar 15; 179 Suppl 2():S342-52. PubMed ID: 10081506 [Abstract] [Full Text] [Related]
19. [Hematopoietic tissue growth factors: clinical factors]. Polli EE, Foa P. Ann Ital Med Int; 1991 Mar 15; 6(1 Pt 1):69-81. PubMed ID: 1716450 [Abstract] [Full Text] [Related]